Patents by Inventor David John Davies

David John Davies has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9005742
    Abstract: A label for removable application to an article such as a beverage bottle includes a backing layer (2) comprising a laminate of a bi-axially oriented polyester such as PET (12) and a bi-axially oriented polypropylene (14). The polyester film (12) has a lower coefficient of thermal expansion than the polypropylene film (14). Consequently, when the label is heated, it will tend to curl and this effect can be used to assist in the removal of the label from the article in a hot washing bath during recycling of the article.
    Type: Grant
    Filed: October 4, 2012
    Date of Patent: April 14, 2015
    Assignee: Spear Group Holdings Limited
    Inventors: David John Davies, Darren Hammonds
  • Publication number: 20110046137
    Abstract: The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof: The pyrazole derivatives of formula (I) or salts thereof modulate P2X7 receptor function and are capable of antagonizing the effects of ATP at the P2X7 receptor (P2X7 receptor antagonists). The invention also relates to the use of such compounds or salts, or pharmaceutical compositions thereof, in the treatment or prevention of disorders/diseases mediated by the P2X7 receptor, for example pain, inflammation or a neurodegenerative disease.
    Type: Application
    Filed: May 8, 2008
    Publication date: February 24, 2011
    Inventors: Paul John Beswick, Laura Jane Chambers, Iain Patrick Chessell, David John Davies, Emmanuel Hubert Demont, Robert James Gleave, David George Hubert Livermore, Pamela Joan Theobald, Mythily Vimal, Daryl Simon Walter
  • Publication number: 20090149524
    Abstract: The present invention relates to novel pyrazole derivatives of formula (I) which bind to the P2X7 receptor and are capable of interfering with the effects of ATP at the P2X7 receptor: and the use of such compounds or pharmaceutical compositions thereof in the treatment of disorders mediated by the P2X7 receptor, for example pain, inflammation and neurodegeneration.
    Type: Application
    Filed: June 5, 2007
    Publication date: June 11, 2009
    Inventors: Paul John Beswick, Laura J. Chambers, David John Davies, David Kenneth Dean, Emmanuel Hubert Demont, Susan Roomans, Daryl Simon Walter